• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov10
Alterity Therapeutics Presents Favorable Data on ATH434 for Orthostatic Hypotension and MSA
12:26
Oct14
Jason McCarthy Issues Buy Rating on Alterity Therapeutics Stock
18:56
Sep29
Alterity Therapeutics Predicts ATH434 Global Peak Sales of $2.4 Billion
05:01
Aug29
Alterity Therapeutics released FY2025 earnings on August 28 (EST), actual revenue USD 3.526 M (forecast USD 3.591 M), actual EPS USD -0.7386 (forecast USD -0.82)
03:00
Alterity Therapeutics released FY2025 9 Months Earnings on August 28 (EST), actual revenue USD 2.259 M, actual EPS USD -0.6765
03:00
Alterity Therapeutics released FY2025 Q3 earnings on August 28 (EST), with actual revenue of USD 1.205 M and EPS of USD -0.1252
03:00

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 1.25 M, Net Income -1.623 M, EPS -0.1299

Feb28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 499.51 K, Net Income -2.231 M, EPS -0.2612

Aug29
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 706.56 K, Net Income -4.208 M, EPS -0.5262

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More